Skip to main content
Premium Trial:

Request an Annual Quote

Telo Genomics Raises $2.1M in Private Placement

NEW YORK — Telo Genomics said on Friday that it has closed the first tranche of a previously announced private placement, raising roughly C$2.1 million ($1.7 million).

The Canadian firm issued 4,185,500 units for C$.50 apiece, with each unit consisting of a common share and half of a warrant to purchase a common share at C$.75 per share. A second tranche is expected to close soon and gross about C$195,000.

Telo said that it would use the proceeds of the private placement to fund its ongoing collaboration with the Mayo Clinic, under which the partners are using the company's proprietary telomere analytics to predict the progression of multiple myeloma.

The money will also be used to build or purchase a CLIA lab, explore the use of Telo's technology for additional indications, and for general working purposes.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.